Literature DB >> 2540024

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.

V Kataja1, K Syrjänen, R Mäntyjärvi, M Väyrynen, S Syrjänen, S Saarikoski, S Parkkinen, M Yliskoski, J T Salonen, O Castren.   

Abstract

A total of 532 women with established cervical HPV infection have been prospectively followed (without treatment) since 1981 for a mean of 45 (SD 21) months. The patients were examined by colposcopy, PAP smears and/or punch biopsy every 6 months. The life-table method was applied to analyze the clinical course (i.e. regression and progression) of the HPV lesions, stratified by their colposcopic pattern, PAP smear findings and grade of CIN. During the follow-up, 107 (41.8%) of 256 patients with HPV-NCIN lesion in the first punch biopsy, experienced spontaneous regression. The corresponding proportions for HPV-CIN I, HPV-CIN II and HPV-CIN III lesions were 31.1%, 34.2%, and 20.7%, respectively. In the overall comparison between these four groups, the heterogeneity in the probability of regression was statistically significant (p = 0.0005). Clinical progression was also associated significantly with the histological grade of the lesions in the first biopsy. Progression rate was only 5.8% for HPV-NCIN lesions, as compared to 12.3% for HPV-CIN I, 20% for HPV-CIN II, and 55.2% for HPV-CIN III. The probability of progression varied significantly between the four groups (p less than 0.00001). Cumulative proportion of regression was 46% for patients with PAP smear class I, 84% with class II, and 82% for those with class III, cells, i.e. PAP smear was not of value in predicting the regression. However, PAP smears predicted clinical progression (p = 0.006 overall).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2540024     DOI: 10.1007/bf00145037

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  29 in total

1.  SOME HISTOLOGICAL ASPECTS OF BEHAVIOR OF EPIDERMOID CARCINOMA IN SITU AND RELATED LESIONS OF THE UTERINE CERVIX. A LONG-TERM PROSPECTIVE STUDY.

Authors:  L G KOSS; F STEWART; F W FOOTE; M J JORDAN; G M BADER; E DAY
Journal:  Cancer       Date:  1963-09       Impact factor: 6.860

Review 2.  Cytologic and histologic manifestations of human papillomavirus infection of the female genital tract and their clinical significance.

Authors:  L G Koss
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women.

Authors:  J K Kulski; M J Howard; E C Pixley
Journal:  Immunol Cell Biol       Date:  1987-02       Impact factor: 5.126

4.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

5.  Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix.

Authors:  K Syrjanen; S Parkkinen; R Mantyjarvi; M Vayrynen; S Syrjanen; H Holopainen; S Saarikoski; O Castren
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

6.  Biologic course of cervical human papillomavirus infection.

Authors:  J D Nash; T W Burke; W J Hoskins
Journal:  Obstet Gynecol       Date:  1987-02       Impact factor: 7.661

7.  Demonstration of human papillomavirus types in paraffin processed tissue from human ano-genital lesions by in-situ DNA hybridisation.

Authors:  M Wells; S Griffiths; F Lewis; C C Bird
Journal:  J Pathol       Date:  1987-06       Impact factor: 7.996

8.  Condylomatous lesions of the cervix and vagina. I. Cytologic patterns.

Authors:  A Meisels; R Fortin
Journal:  Acta Cytol       Date:  1976 Nov-Dec       Impact factor: 2.319

9.  Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policy.

Authors:  J B Murdoch; L J Cassidy; K Fletcher; J W Cordiner; J C Macnab
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-06

Review 10.  Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence.

Authors:  N Muñoz; X Bosch; J M Kaldor
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

View more
  20 in total

1.  Antibiotic prophylaxis for cold coagulation of the cervix.

Authors:  K Woodcock
Journal:  Genitourin Med       Date:  1992-06

2.  Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Teresa M Darragh; Adaleen Powers; Sepideh Farhat; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

Review 3.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

4.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.

Authors:  K Cooper; C S Herrington; J E Stickland; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

5.  Screening Sexually Active Teenagers for Cervical Abnormalities: Its importance for sexually active teenagers.

Authors:  J Erdstein; A V Pavilanis
Journal:  Can Fam Physician       Date:  1991-05       Impact factor: 3.275

6.  Conization for CIN associated with human papillomavirus infection.

Authors:  M Yliskoski; S Saarikoski; K Syrjänen
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

7.  Papillomavirus-associated balanoposthitis.

Authors:  A Wikström; G von Krogh; M A Hedblad; S Syrjänen
Journal:  Genitourin Med       Date:  1994-06

8.  Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types.

Authors:  D Hellberg; S Nilsson; A Gad; J Hongxiu; C Fuju; S Syrjänen; K Syrjänen; A ] Grad A [corrected to Gad
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

9.  Efficacy trial of topically administered interferon gamma-1 beta gel in comparison to laser treatment in cervical intraepithelial neoplasia.

Authors:  A Schneider; T Grubert; R Kirchmayr; D Wagner; U Papendick; G Schlunck
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 10.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.